Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dissecting genomic correlates of response and resistance to chemotherapy in bladder cancer through clinical computational oncology
    Meeting Abstract

    Liu, D.; Abbosh, P.; Keliher, D.; Reardon, B.; Miao, D.; Mouw, K.; Weiner-Taylor, A.; Wankowicz, S.; Han, G.; Teo, M. Y.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of >1000 plasma and tumor tissue samples from metastatic castration-resistant prostate cancer (mCRPC) patients gives insight into targeted treatment strategies
    Meeting Abstract

    Green, F.; Shapiro, J. D.; McDermott, R.; Piulats, J. M.; Reid, A.; Ostler, P.; Zhang, J.; Campbell, D.; Spaeth, D.; Percent, I.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • ATLAS: A Phase II, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Grivas, P.; Teo, M. Y.; Vogelzang, N.; Alva, A.; Zakharia, Y.; Adra, N.; Drakaki, A.; Hussain, A.; Morales-Barrera, R.; Necchi, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Drug repurposing engine fueled by diverse drug similarity data
    Meeting Abstract

    Elkhader, J. A.; Gilvary, C. M.; Madhukar, N. S.; Elemento, O.; Solit, D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy
    Meeting Abstract

    Fernandez, L.; Poirier, J.; Rodriguez, A.; Hulling, M.; Richardson, R.; Sutton, R.; Jiles, R.; Schonhoft, J.; Lee, J.; Ebrahim, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Meeting Abstract

    Atiq, M.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Zygosity, lineage, and penetrance dictate the role of germline pathogenicity in tumorigenesis
    Meeting Abstract

    Bandlamudi, C.; Srinivasan, P.; Jonsson, P.; Kemel, Y. M.; Chavan, S. S.; Richards, A. L.; Penson, A.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A Phase Ib/IIa study of the BET bromodomain inhibitor ZEN-3694 in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Aggarwal, R.; Abida, W.; Schweizer, M.; Pantuck, A.; Nanus, D.; Heath, E.; Lakhotia, S.; Hansen, H.; Silverman, M.; Bauman, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save